01/11/2012 at 3:08PM, Geron Corp. (GERN) hired Stifel Nicolaus (SF) & Co. to sell its embryonic stem cell therapy, the first approved in the U.S., as the company changes its focus to cancer drugs, Chief Executive Officer John Scarlett said.
Good luck in this rigged casino,
No comments:
Post a Comment